Apalutamide Recruiting Phase 2 Trials for Stage II Prostate Adenocarcinoma AJCC v7 / Stage II Prostate Adenocarcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02721979Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance